位置:成果数据库 > 期刊 > 期刊详情页
Maxadilan对人脂肪干细胞的影响
  • ISSN号:1000-4718
  • 期刊名称:《中国病理生理杂志》
  • 时间:0
  • 分类:R363[医药卫生—病理学;医药卫生—基础医学]
  • 作者机构:[1]暨南大学 附属第一医院眼科,广东广州510632, [2]暨南大学 再生医学教育部重点实验室,广东广州510632, [3]医学院眼科研究所,广东广州510632
  • 相关基金:国家自然科学基金资助项目(No.81371689); 广东省自然科学基金资助项目(No.S2013010013391)
中文摘要:

目的:探讨垂体腺苷酸环化酶激活肽Ⅰ型受体(PAC1受体)特异激动剂maxadilan对人脂肪干细胞(adipose-derived stem cells,ASCs)的增殖、凋亡和分化潜能的作用。方法:取人脂肪组织通过酶消化法分离培养ASCs。流式细胞术鉴定ASCs表面标志物,并进行ASCs向成骨成脂定向诱导。CCK-8法和流式细胞术检测maxadilan对ASCs活性的影响。采用波长为254 nm的紫外线(ultraviolet C,UVC)照射ASCs,CCK-8法测定不同剂量的UVC诱导ASCs凋亡后的吸光度。选择剂量为702 J/m2的UVC照射ASCs 24 h后,用流式细胞术和caspase 3和caspase 9试剂盒检测maxadilan对ASCs凋亡的影响。结果:流式细胞术检测表明细胞CD29、CD44、CD59和CD105表面抗原阳性,证实所提取的细胞是ASCs。CCK-8法检测发现80 nmol/L浓度的maxadilan对ASCs促增殖作用最强,流式细胞术分析也证实80 nmol/L maxadilan处理显著促进ASCs的增殖,与对照组比较差异有统计学意义(P〈0.05)。与仅被702 J/m2UVC照射的ASCs比较,80 nmol/L maxadilan显著抑制同等剂量UVC照射ASCs所诱导的、与caspase 3和caspase 9活性相关的细胞凋亡,2组比较差异有统计学意义(P〈0.05)。同时,2组细胞成骨和成脂的诱导分化均为阳性。结论:Maxadilan促进ASCs增殖,抑制ASCs凋亡,且不改变细胞向成骨和成脂诱导分化的潜能。Maxadilan有利于ASCs的体外生长与扩增。

英文摘要:

AIM:To investigate the effect of maxadilan, which specifically activates pituitary adenylate cycla-se-activating polypeptide type I receptor (PAC1 receptor), on the proliferation, apoptosis and differentiation potential of human adipose-derived stem cells ( ASCs) .METHODS:ASCs from human adipose tissue were isolated by enzymatic di-gestion and cultured.ASCs were confirmed by the analysis of the markers for cell phenotypes by flow cytometry ( FCM) and adipogenic/osteogenic induction.The effect of maxadilan on ASCs viability was analyzed by CCK-8 assay and FCM.ASCs were irradiated by ultraviolet C ( UVC) at 254 nm and the absorbance of apoptotic ASCs induced by various doses of UVC was measured by CCK-8 assay.ASCs were exposed to 702 J/m2 UVC for 24 h to induce apoptosis.The effect of maxadilan on ASC apoptosis was analyzed by FCM and the determination of caspase 3 and caspase 9 levels.RESULTS:Adipose-de-rived stem cells were confirmed by the detection of the positive expression of cell phenotypes including CD29, CD44, CD59 and CD105 by FCM.The data of CCK-8 assay revealed that ASCs treated with maxadilan (80 nmol/L) had the strongest ability of proliferation.The data of FCM also demonstrated that the addition of 80 nmol/L maxadilan to ASCs in experimen-tal group markedly improved the proliferation capacity of the cells compared with control group (P〈0.05).The apoptosis of ASCs exposed to 702 J/m2UVC was dramatically inhibited by the treatment with maxadilan (80 nmol/L).Such process involved the caspase signaling pathway including caspase 3 and caspase 9.There was statistical significance (P〈0.05) between experiment group ( ASCs irradiated by UVC and supplemented with maxadilan) and control group ( ASCs only irra-diated by UVC) .Meanwhile, adipogenic and osteogenic differentiation potentials were both positive in experiment group and control group.CONCLUSION:Maxadilan promotes proliferation and inhibits apoptosis of the ASCs.The differentia-tion potential of ASCs

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国病理生理杂志》
  • 中国科技核心期刊
  • 主管单位:中国科学技术协会
  • 主办单位:中国病理生理学会
  • 主编:陆大祥
  • 地址:广东省广州市黄埔大道西601号
  • 邮编:510632
  • 邮箱:obsbjbb@jnu.edu.cn
  • 电话:020-85220269
  • 国际标准刊号:ISSN:1000-4718
  • 国内统一刊号:ISSN:44-1187/R
  • 邮发代号:46-98
  • 获奖情况:
  • 1997-2000年连续获得中国科协优秀基础性和高科技...,1992、1996、2000、2004、2008年,连续五次入选中...,2008-2010年,连续三年荣获“百种中国杰出学术期...,2010年获广东省期刊最高奖——品牌期刊奖
  • 国内外数据库收录:
  • 美国化学文摘(网络版),日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:37010